About FemaSeed FemaSeed is a next-generation artificial insemination solution that enhances fertilization by precisely delivering sperm to the fallopian tube, the natural site of conception. Offering a safe, accessible, and cost-effective first- line treatment, FemaSeed provides a more effective alternative to intrauterine insemination (IUI). In the pivotal clinical trial (NCT0468847), it achieved over double the pregnancy rates of IUI in cases of low male sperm count. FemaSeed is an affordable, less invasi ...

"Varonis' SaaS platform integrates the most advanced capabilities in Microsoft Azure," said Nick Parker, President of Industry and Partnerships at Microsoft. "Through our collaboration with Varonis, we are empowering customers to embrace AI securely and confidently with enterprise-wide data security and governance powered by Microsoft Purview and Varonis." As part of the collaboration, Varonis' integration with Microsoft Purview aims to deliver unified data classification, permissions enforcement, and polic ...

Additional information: Karri Alameri, CEO, tel. +358 45 656 5250, karri.alameri@omasp.fi Distribution: OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE 1 JULY 2025 AT 4:00 PM CHANGES IN BOARD/MANAGEMENT/AUDITORS Pekka Pykäri steps down from his role in Oma Savings Bank's management team Oma Savings Bank's Chief Risk Officer (CRO) and member of the management team, Pekka Pykäri, will step down at his own request no later than August 31, 2025. Pekka Pykäri will continue working for the company in other risk cont ...

The prospective multi-center, single-arm study used MAGiC to treat patients with a broad spectrum of arrhythmia – atrioventricular nodal reentrant tachycardia, Wolf-Parkinson-White syndrome, atrial fibrillation, atrial flutter, premature ventricular contractions, and ventricular tachycardia – in all four chambers of the heart. The initial analysis of the study includes acute efficacy and safety for 67 patients. Patient enrollment is ongoing with approximately a hundred patients enrolled to date and continue ...

VANCOUVER, Wash., July 01, 2025 (GLOBE NEWSWIRE) -- Riverview Bancorp, Inc. (Nasdaq GSM: RVSB) ("Riverview" or the "Company") today announced it was added to the Russell 3000 Index® and Russell 2000® Index when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes on June 30, 2025. "Being added to the Russell 2000® Index is an important milestone for Riverview and reflects the strong progress we have made in growing the value of our franchise and increasing shareholder va ...

Modernization of legacy IT systems remains critical to meeting data security, privacy, and scalability demands for healthcare organizations SAN JOSE, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- Nutanix (NASDAQ: NTNX), a leader in hybrid multicloud computing, announced the findings of its seventh annual global Healthcare Enterprise Cloud Index (ECI) survey and research report, which measures enterprise progress with cloud adoption in the industry. The research showed that 99% of healthcare organizations survey ...

In H1 2025, Apranga Group opened 1 new store, renovated 5 stores, out of which 3 were enlarged, and closed 3 stores. Currently Apranga Group operates the chain of 169 stores (102 in Lithuania, 43 in Latvia and 24 in Estonia) covering the gross area of 92.2 thousand sq. m., or by 1.3% more than a year ago. Rimantas Perveneckas "Apranga" Group General Manager +370 5 2390801 Retail turnover (including VAT) of Apranga Group amounted to EUR 34.0 million in June 2025 and increased by 13.8% compared to June 2024. ...

Signed binding term sheet granting Intact Therapeutics an exclusive option to license PCS12852 VERO BEACH, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage pharmaceutical company developing next-generation cancer therapies, provides updates on its product pipeline, upcoming milestones and business activities. "We are taking deliberate steps to focus our resources on programs with the highest potential for clinical success and commercial impact," said Dr ...

-Trinity Biotech projects it reached Adjusted EBITDA -positive operations during Q2 2025 and expects to be Adjusted EBITDA positive going forward, reflecting continued strong execution on its comprehensive transformation plan.- - The Company now expects to be meaningfully Adjusted EBITDA -positive and cashflow positive from ongoing operating activities, starting Q3 2025 and into the foreseeable future.- DUBLIN, July 01, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechn ...

Young Chinese rider Neisen Zhang dominates US Sprint Enduro series with six victories in seven rounds HANGZHOU, China, July 01, 2025 (GLOBE NEWSWIRE) -- Apollino (Zhejiang Apollo Sports Technology Co., Ltd.) today announced that racing team rider Neisen Zhang (Ken Ken) has secured the 2025 AMA US Sprint Enduro (USSE) championship, demonstrating the growing presence of Chinese youth in American motorsports and showcasing the effectiveness of Apollino's youth development programs. The USSE, based on Internati ...